EARLY CONCOMITANT IMMUNOMODULATOR TREATMENT PROVIDES ADDITIONAL BENEFIT IN INFLIXIMAB TREATED PEDIATRIC IBD PATIENTS DESPITE PROACTIVE DRUG MONITORING: RETROSPECTIVE ANALYSIS OF A 10-YEAR REAL-LIFE COHORT

Lena Bragagna  ¹     Hannes Hölz  ¹     Thu Giang Le Thi  ¹     Anna Littwin  ¹     Milena Geist  ¹     Sibylle Koletzko  ^{1, 2}     Tobias Schwerd  ^2    
1 Dr. von Hauner Children´s Hospital, München, Germany
² School of Medicine Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland

Topic
IBD

Session
IBD: We treat them all - but how? (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)